. 2017 Jul 11;7:5129. doi: 10.1038/s41598-017-05311-2

Table 1.

Correlation between GTSE1 and clinicopathological features in patients with HCC.

		GTSE1 (n = 89)		P value
		Low expression (n = 47)	High expression (n = 42)	P value
1. Age (year)	≤50	30	19	0.078
1. Age (year)	>50	17	23	0.078
2. Gender	Male	37	34	0.794
2. Gender	Female	10	8	0.794
3. Size of tumour	≤5 cm	19	19	0.710
3. Size of tumour	>5 cm	27	23	0.710
4. Number of tumours	1	46	29	<0.001**
4. Number of tumours	≥2	1	12	<0.001**
5. Histological differentiation	High	2	4	0.257
	Medium	36	25
	Low	8	11
6. Tumour thrombus	No	37	38	0.714
6. Tumour thrombus	Yes	3	5	0.714
7. Lymphnode metastasis	No	44	34	0.291
7. Lymphnode metastasis	Yes	3	6	0.291
8. HBV DNA	≤1e5	38	23	0.036*
8. HBV DNA	>1e5	8	14	0.036*
9. Tumour relapse	No	30	30	0.631
9. Tumour relapse	Yes	15	12	0.631
10. AFP (ng/mL)	≤500	27	16	0.016*
10. AFP (ng/mL)	>500	4	11	0.016*

AFP, alpha-fetoprotein; *P < 0.05, **P < 0.01.